Domain Services

Let us manage your domain name portfolio.

Domain names are one of the most important assets a company can hold, especially if you have an online focus. When a company has hundreds or thousands of domain names it can become difficult to manage. Let us take that problem away from you. Safenames has been an ICANN accredited registrar for almost 20 years, specialising in corporate domain name portfolio management. We can automatically renew your domains, manage your DNS and monitor for any infringements against your brand online.

Why choose Safenames?

Register Domains Quickly

Product launches and business plans evolve at a fast pace, don't let the domain registration process slow down your business plans.

Direct Registry Connection

Register domains with a company that works directly with registries rather than a company who uses resellers.

Expert Guidance

Follow the rules and regulations for existing domain extensions or new TLD launches by working directly with your dedicated domain consultant.

Safenames Blog

Stay current on important topics that impact your domain portfolio and brands online

Cybersquatting and Opportunism: The Heightened Threat During Coronavirus - Part 1

May 21, 2020, 15:41 PM

As we are all aware, the world is battling a deadly outbreak of a novel coronavirus, COVID-19. The virus is dominating our lives, and it may do for some time yet.

Despite the harm caused by COVID-19, many have found it to be a chance to show the best of humanity. Stories of generosity and charity abound across the world.

On the other hand, we have the scammers who take any opportunity to deceive for their own gain. Domain names, as the ‘indicators of origin’ for the internet, are used as vehicles to deliver fraud to unwary, and often vulnerable, online users.

There is an enticing commercial opportunity to cash-in on a trend, movement, or even a crisis. Just as the word ‘Brexit’ dominated news headlines, there were those who tried making a quick buck: from Brexit-related merchandise to Brexit-related scams.

We often see a rush of trademark registrations when a trending word or phrase appears. The same is true for domain names – unsurprising given the internet is now the medium most used to transmit and take advantage of worldwide trends.

There is evidence of an increase in terms such as ‘coronavirus’ and ‘COVID-19’ being used in domain names, often combined with a trusted brand name or trademark. Many such domain names aim to deceive the public. The use of established brands in domain names, termed ‘cybersquatting’, is the Trojan horse which enables fearmongering, financial fraud and counterfeits to thrive online.

Fortunately, there are ways for brand owners to combat what we refer to as ‘opportunistic cybersquatting’.

How are brand owners affected?

It is vital to be aware of the ways in which misleading domain names can be used to hurt brands and businesses.

Take, for example, the typical ‘CEO’ phishing attack: this is where scammers use a deceptive domain name to fake the email address of a company’s CEO, or other Board member, to scam the company’s employees. This scam can be very potent in the current chaotic business climate; unusual requests for account details or financial transactions may seem more legitimate.

Thankfully, registrars and financial authorities are taking action to stem the flow of fraud1. Proactive brand owners are also starting to enforce their rights against infringing domain names. This can be done through domain name arbitration, such as the Uniform Domain Name Dispute Resolution Policy (‘UDRP’), which results in malicious domain names being transferred to the rightful owner.

The first ‘coronavirus’ UDRP case was filed on March 19th, regarding "coronavirusgoogle.com". Google have already recovered "googlecoronavirus.com" through the UDRP, after the owner consented to the transfer of the domain name. In addition to these two Google cases, fellow tech giant Facebook are involved in a dispute over "facebookcovid19.com".

Both Google and Facebook have seen the potential threat behind these domain names. Both companies are involved in a constant herculean struggle against campaigns of misinformation, which present a real danger to the public2. This epidemic has, perhaps inevitably, brought to shore a fresh wave of misleading articles, malicious conspiracy theories and misplaced advice about treatments for COVID-19.

Pharmaceutical companies in particular must be wary of cybersquatting threats. Fraudsters take advantage of hype about drugs that are rumoured to treat COVID-19. Counterfeits of these drugs can be sold online, using trademarked names for the drugs in the domain name to attract internet traffic and imply endorsement.

We may already have an example of the above. There are three ongoing UDRP cases involving the “KALETRA” drug. In one case, the disputed domain names resolve to a website advertising the drug for sale, within the context of treating coronavirus. “KALETRA” has been subject to scientific study regarding its capability to combat the virus, but no clear benefit in taking the drug was found3 We eagerly await the full facts of this case to emerge.

It is clear that tackling trademark misuse in domain names, in the current climate, is not just about guarding against brand tarnishing or dilution – it is a fight for public safety. As global lockdowns keep people indoors, their internet exposure will only increase. It is crucial that this digital medium stays secure, instead of being used for deception and fraud.

Thankfully, speedy arbitration mechanisms, such as the UDRP, are already equipped to deal with opportunistic cybersquatting, as will be demonstrated in Part II.

1 https://www.infosecurity-magazine.com/news/domain-registrars-combat-covid-19/ and https://www.consumer.ftc.gov/features/coronavirus-scams-what-ftc-doing

2 See https://www.bloomberg.com/news/articles/2020-03-10/dr-google-scrubs-coronavirus-misinformation-on-search-youtube and https://www.campaignlive.co.uk/article/coronavirus-misinformation-slipping-facebooks-ad-review-system/1679843

3 https://www.fiercepharma.com/pharma-asia/does-abbvie-s-hiv-drug-kaletra-also-works-covid-19-maybe-not-nejm-study-finds


Let's talk

See how Safenames can help your business